Stocks and Investing
Stocks and Investing
Mon, July 30, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Gerberry Maintained (ABBV) at Strong Buy with Decreased Target to $105 on, Jul 30th, 2018
Jason Gerberry of B of A Securities, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $112 to $105 on, Jul 30th, 2018.
Jason has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018
These are the ratings of the 3 analyists that currently disagree with Jason
- David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $130 on, Monday, June 11th, 2018
- Vamil Divan of "Credit Suisse" Downgraded from Hold to Sell and Decreased Target to $89 on, Wednesday, May 30th, 2018
- Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $78 on, Wednesday, May 23rd, 2018